RonaldGansevoort Dept. Nephrology, University Medical Center Groningen

Ron T. Gansevoort, MD PhD, FERA, FASN, is professor of Medicine and nephrologist at the UMC Groningen, the Netherlands. His work has been instrumental in the development of the definition and classification of CKD, the development of novel endpoints for clinical trials in Nephrology and the first registered treatment for ADPKD. He is committed to getting more attention for screening for early CKD and prevention of progressive kidney function loss on a general population level, and specifically also in patients with ADPKD. At his institution he established the PKD Expertise Center, that has been acknowledged as such by the Dutch and EU authorities. Professor Gansevoort has co-authored over 700 peer reviewed manuscripts (h-index 103), and is/was member of the steering committee of several large scale consortia (among others the CKD-Prognosis Consortium, DIPAK, ERACODA and RECOVAC) and clinical trials in the field of CKD (ARTS-DN, CONCORD, Renal Lifecycle) and ADPKD (TEMPO 3:4, REPRISE, DIPAK-1, STAGED-PKD, MANGROVE).